L&G Healthcare Breakthrough

ETF description

This ETF invests in companies involved in innovative areas of healthcare, focusing on advancements in medical treatments, technology, and solutions aimed at improving health outcomes. The fund includes businesses engaged in fields such as biotechnology, pharmaceuticals, medical devices, and healthcare services. These companies are at the forefront of developing breakthrough treatments, cutting‑edge diagnostic tools, and other innovations that address critical health challenges.

This ETF may appeal to investors who are interested in the future of healthcare and the potential of new medical technologies.

Issuer details

Legal & General Investment Management (LGIM) is one of Europe’s largest asset managers and a subsidiary of Legal & General Group plc. With over £1.5 trillion in assets under management as of June 2024. Established in 1836, LGIM has a long history and is known for its strong focus on index investing, providing investors with cost‑effective and diversified exposure to various markets. LGIM is also recognized for its innovative ESG integration across its investment strategies and expertise in liability‑driven investment (LDI) solutions. Notable ETFs include the L&G Global Technology Leaders UCITS ETF and the L&G Cyber Security UCITS ETF, reflecting LGIM’s commitment to providing access to innovative and thematic investment themes. LGIM offers a range of investment solutions and covers various market segments.

Index details

The Healthcare Breakthrough index offers investors a comprehensive measure of performance for companies within the healthcare sector that are driving innovation and technological advancements. By focusing on groundbreaking research and development, the index provides valuable insights into leaders in healthcare innovation.